Publications

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin lymphoma in the United States: A budgetary impact analysis. Abstract C14. Academy of Managed Care Pharmacy 26^th Annual Meeting & Expo 2014.

Jensen IS, Halbert RJ, Grosvenor A, Swartz E, Rossi G, Naoshy S, et al. Incorporating stakeholder input into budget impact models to compare stem cell mobilization strategies. Abstract PCN43. ISPOR 18th Annual International Meeting, 2013.

Cyr P, Sidhu M, Hussain R, Hromin T, Jensen I, Kuan R. Dual-acting osmotic and stimulant laxative for bowel cleansing in an elderly population: A US payer budget impact analysis. Abstract PCN22. ISPOR 18th Annual International Meeting, 2013.

Jensen I, Ogborne R, Cyr P. A German hospital budget impact model comparing antibiotic therapies in complicated skin and skin structure infections and bacteremia. ISPOR 17th Annual International Meeting, 2012.

Jensen I, Helm T, Cyr P. Impact of complications in solid organ transplants on hospital charges and length of stay. Abstract PSU15. ISPOR 17th Annual International Meeting, 2012.

Jensen I, Helm T, Cyr P. Impact of dysphagia on U.S. hospital charges in patients with comorbid conditions. Abstract PGI9. ISPOR 14th Annual European Congress, 2011.

Jensen I, Helm T, Cyr P. Impact of complications from dysphagia on hospital charges in the United States. Abstract PGI7. ISPOR 14th Annual European Congress, 2011.

Mcnamara JF, Lombardo H, Pillai SK, Jensen I, Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A.

Casale RA, Jensen IS, Egholm M. 1999. Synthesis of PNA oligomers by Fmoc chemistry. In Peptide Nucleic Acids: Protocols & Applications. Weymondham, UK: Horizon Scientific Press.

McNamara JF, Lombardo H, Pillai SK, Jensen IS, Kates SA. A comparison of solid-phase techniques for the construction of chemokines. In Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Segal BM, McNamara JF, Jensen IS, Kates SA, Holm RH. Design and synthesis of cyclic peptides for iron-sulfur cluster assembly and encapsulation. In: Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Jensen IS, McNamara JF, Lombardo H, Pillai SK, Kates SA. Solid-phase assembly of chemokines: A survey of synthetic approaches to RANTES. Twelfth Symposium of the Protein Society. San Diego, CA, July 1998.

Casale RA, Paul CH, Jensen IS, Moyer ML, Kates SA, Egholm M. 1998. A comparison of solid supports for PNA synthesis. In Epton R (ed), Innovation and Perspectives in Solid Phase Synthesis and Combinatorial Libraries. Birmingham, England: Mayflower Worldwide Limited.

Casale RA, Leete T, Daniels S, Jensen IS, Moyer M, Egholm M. Improvements in PNA synthesis using the Expedite Nucleic Acid Synthesis System. Large Scale Oligonucleotide round table, San Diego, CA, 1997.